Please enable Javascript

Labmeeting uses lots of Javascript - basically you can't use the site without it. So please enable Javascript in your browser. If your browser does not support Javascript, we recommend Firefox.

Papers authored by Hollema H

Collect these papers and discover other ones on Labmeeting. Learn more.

Immunization with a P53 synthetic long peptide vaccine induces P53-specific immune responses in ovarian cancer patients, a phase II trial.

+ cite this

+ View Abstract

Leffers N, Lambeck AJ, Gooden MJ, Hoogeboom BN, Wolf R, Hamming IE, Hepkema BG, Willemse PH, Molmans BH, Hollema H, Drijfhout JW, Sluiter WJ, Valentijn AR, Fathers LM, Oostendorp J, van der Zee AG,

(show remaining authors)

International journal of cancer. Journal international du cancer 125(9):2104-13, 2009 Nov 1 - Who cited this? | PubMed ID: 19621448 | Fulltext

Mononucleotide precedes dinucleotide repeat instability during colorectal tumour development in Lynch syndrome patients.

+ cite this

+ View Abstract

Ferreira AM, Westers H, Sousa S, Wu Y, Niessen RC, Olderode-Berends M, van der Sluis T, Reuvekamp PT, Seruca R, Kleibeuker JH, Hollema H, Sijmons RH, and Hofstra RM

The Journal of pathology 219(1):96-102, 2009 Sep - Who cited this? | PubMed ID: 19521971 | Fulltext

The prognostic value of TRAIL and its death receptors in cervical cancer.

+ cite this

+ View Abstract

Maduro JH, Noordhuis MG, ten Hoor KA, Pras E, Arts HJ, Eijsink JJ, Hollema H, Mom CH, de Jong S, de Vries EG, de Bock GH, and van der Zee AG

International journal of radiation oncology, biology, physics 75(1):203-11, 2009 Sep 1 - Who cited this? | PubMed ID: 19695437 | Fulltext

P-gp and MRP1 expression in parathyroid tumors related to histology, weight and (99m)Tc-sestamibi imaging results.

+ cite this

+ View Abstract

Jorna FH, Hollema H, Hendrikse HN, Bart J, Brouwers AH, and Plukker JT

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 117(8):406-12, 2009 Sep - Who cited this? | PubMed ID: 19235131 | Fulltext

Germline hypermethylation of MLH1 and EPCAM deletions are a frequent cause of Lynch syndrome.

+ cite this

+ View Abstract

Niessen RC, Hofstra RM, Westers H, Ligtenberg MJ, Kooi K, Jager PO, de Groote ML, Dijkhuizen T, Olderode-Berends MJ, Hollema H, Kleibeuker JH, and Sijmons RH

Genes, chromosomes & cancer 48(8):737-44, 2009 Aug - Who cited this? | PubMed ID: 19455606 | Fulltext

Presence of tumor-infiltrating lymphocytes is an independent prognostic factor in type I and II endometrial cancer.

+ cite this

+ View Abstract

de Jong RA, Leffers N, Boezen HM, ten Hoor KA, van der Zee AG, Hollema H, and Nijman HW

Gynecologic oncology 114(1):105-10, 2009 Jul - Who cited this? | PubMed ID: 19411095 | Fulltext

Do microsatellite instability profiles really differ between colorectal and endometrial tumors?.

+ cite this

+ View Abstract

Ferreira AM, Westers H, Wu Y, Niessen RC, Olderode-Berends M, van der Sluis T, van der Zee AG, Hollema H, Kleibeuker JH, Sijmons RH, and Hofstra RM

Genes, chromosomes & cancer 48(7):552-7, 2009 Jul - Who cited this? | PubMed ID: 19373783 | Fulltext

Routine follow-up intervals in patients with high-grade squamous intraepithelial lesions (HSIL) and free excision margins can safely be increased in the first two years after Large Loop Excision of the Transformation Zone (LLETZ).

+ cite this

+ View Abstract

Eijsink JJ, de Bock GH, Kuiper JL, Reesink-Peters N, van Hemel BM, Hollema H, Nijman HW, Mourits MJ, and van der Zee AG

Gynecologic oncology 113(3):348-51, 2009 Jun - Who cited this? | PubMed ID: 19297014 | Fulltext

Down-regulation of proteasomal subunit MB1 is an independent predictor of improved survival in ovarian cancer.

+ cite this

+ View Abstract

Leffers N, Gooden MJ, Mokhova AA, Kast WM, Boezen HM, Ten Hoor KA, Hollema H, Daemen T, van der Zee AG, and Nijman HW

Gynecologic oncology 113(2):256-63, 2009 May - Who cited this? | PubMed ID: 19243813 | Fulltext

Effect of tamoxifen on the endometrium and the menstrual cycle of premenopausal breast cancer patients.

+ cite this

+ View Abstract

Buijs C, Willemse PH, de Vries EG, Ten Hoor KA, Boezen HM, Hollema H, and Mourits MJ

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 19(4):677-81, 2009 May - Who cited this? | PubMed ID: 19509569 | Fulltext

Aromatase, cyclooxygenase 2, HER-2/neu, and p53 as prognostic factors in endometrioid endometrial cancer.

+ cite this

+ View Abstract

Jongen VH, Briët JM, de Jong RA, Joppe E, ten Hoor KA, Boezen HM, Evans DB, Hollema H, van der Zee AG, and Nijman HW

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 19(4):670-6, 2009 May - Who cited this? | PubMed ID: 19509570 | Fulltext

PMS2 involvement in patients suspected of Lynch syndrome.

+ cite this

+ View Abstract

Niessen RC, Kleibeuker JH, Westers H, Jager PO, Rozeveld D, Bos KK, Boersma-van Ek W, Hollema H, Sijmons RH, and Hofstra RM

Genes, chromosomes & cancer 48(4):322-9, 2009 Apr - Who cited this? | PubMed ID: 19132747 | Fulltext

Microarray methods to identify factors determining breast cancer progression: potentials, limitations, and challenges.

+ cite this

+ View Abstract

van der Vegt B, de Bock GH, Hollema H, and Wesseling J

Critical reviews in oncology/hematology 70(1):1-11, 2009 Apr - Who cited this? | PubMed ID: 18848465 | Fulltext

Management of extracolonic tumours in patients with Lynch syndrome.

+ cite this

+ View Abstract

Koornstra JJ, Mourits MJ, Sijmons RH, Leliveld AM, Hollema H, and Kleibeuker JH

The lancet oncology 10(4):400-8, 2009 Apr - Who cited this? | PubMed ID: 19341971 | Fulltext

Enhanced Antitumor Efficacy of a DR5-Specific TRAIL Variant over Recombinant Human TRAIL in a Bioluminescent Ovarian Cancer Xenograft Model.

+ cite this

+ View Abstract

Duiker EW, de Vries EG, Mahalingam D, Meersma GJ, Boersma-van Ek W, Hollema H, Lub-de Hooge MN, van Dam GM, Cool RH, Quax WJ, Samali A, van der Zee AG, and de Jong S

Clinical cancer research : an official journal of the American Association for Cancer Research 15(6):2048-57, 2009 Mar 15 - Who cited this? | PubMed ID: 19276284 | Fulltext

Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer.

+ cite this

+ View Abstract

Leffers N, Gooden MJ, de Jong RA, Hoogeboom BN, ten Hoor KA, Hollema H, Boezen HM, van der Zee AG, Daemen T, and Nijman HW

Cancer immunology, immunotherapy : CII 58(3):449-59, 2009 Mar - Who cited this? | PubMed ID: 18791714 | Fulltext

Expression of estrogen receptor-alpha and -beta and progesterone receptor-A and -B in a large cohort of patients with endometrioid endometrial cancer.

+ cite this

+ View Abstract

Jongen V, Briët J, de Jong R, Ten Hoor K, Boezen M, van der Zee A, Nijman H, and Hollema H

Gynecologic oncology 112(3):537-42, 2009 Mar - Who cited this? | PubMed ID: 19108875 | Fulltext

Role of endocervical curettage in the preoperative staging of endometrial carcinoma.

+ cite this

+ View Abstract

Bijen CB, de Bock GH, Ten Hoor KA, Nijman HW, Hollema H, and Mourits MJ

Gynecologic oncology 112(3):521-5, 2009 Mar - Who cited this? | PubMed ID: 19135711 | Fulltext

Survival-related profile, pathways, and transcription factors in ovarian cancer.

+ cite this

+ View Abstract

Crijns AP, Fehrmann RS, de Jong S, Gerbens F, Meersma GJ, Klip HG, Hollema H, Hofstra RM, Meerman GJ, de Vries EG, and van der Zee AG

PLoS medicine 6(2):e24, 2009 Feb 3 - Who cited this? | PubMed ID: 19192944 | Fulltext

Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma.

+ cite this

+ View Abstract

Qi L, Bart J, Tan LP, Platteel I, Sluis T, Huitema S, Harms G, Fu L, Hollema H, and Berg A

BMC cancer 9:163, 2009 - Who cited this? | PubMed ID: 19473551 | Fulltext

Prognosis of uterine corpus cancer after tamoxifen treatment for breast cancer.

+ cite this

+ View Abstract

Hoogendoorn WE, Hollema H, van Boven HH, Bergman E, de Leeuw-Mantel G, Platteel I, Fles R, Nederlof PM, Mourits MJ, van Leeuwen FE, and Comprehensive Cancer Centers TAMARISK-group

Breast cancer research and treatment 112(1):99-108, 2008 Nov - Who cited this? | PubMed ID: 18064567 | Fulltext

A robust ex vivo model for evaluation of induction of apoptosis by rhTRAIL in combination with proteasome inhibitor MG132 in human premalignant cervical explants.

+ cite this

+ View Abstract

Hougardy BM, Reesink-Peters N, van den Heuvel FA, ten Hoor KA, Hollema H, de Vries EG, de Jong S, and van der Zee AG

International journal of cancer. Journal international du cancer 123(6):1457-65, 2008 Sep 15 - Who cited this? | PubMed ID: 18567003 | Fulltext

The ErbB signalling pathway: protein expression and prognostic value in epithelial ovarian cancer.

+ cite this

+ View Abstract

de Graeff P, Crijns AP, ten Hoor KA, Klip HG, Hollema H, Oien K, Bartlett JM, Wisman GB, de Bock GH, de Vries EG, De Jong S, and van der Zee AG

British journal of cancer 99(2):341, 2008 Jul 22 - Who cited this? | PubMed ID: 18628764 | Fulltext

Early carcinogenic events in HNPCC adenomas: differences with sporadic adenomas.

+ cite this

+ View Abstract

Rijcken FE, Koornstra JJ, van der Sluis T, Boersma-van EW, Kleibeuker JH, and Hollema H

Digestive diseases and sciences 53(6):1660-8, 2008 Jun - Who cited this? | PubMed ID: 17999188 | Fulltext

Population pharmacokinetics and pharmacodynamics of Paclitaxel and Carboplatin in ovarian cancer patients: a study by the European organization for research and treatment of cancer-pharmacology and molecular mechanisms group and new drug development group.

+ cite this

+ View Abstract

Joerger M, Huitema AD, Richel DJ, Dittrich C, Pavlidis N, Briasoulis E, Vermorken JB, Strocchi E, Martoni A, Sorio R, Sleeboom HP, Izquierdo MA, Jodrell DI, Calvert H, Boddy AV, Hollema H,

(show remaining authors)

Clinical cancer research : an official journal of the American Association for Cancer Research 13(21):6410-8, 2007 Nov 1 - Who cited this? | PubMed ID: 17975154 | Fulltext

MEIS and PBX homeobox proteins in ovarian cancer.

+ cite this

+ View Abstract

Crijns AP, de Graeff P, Geerts D, Ten Hoor KA, Hollema H, van der Sluis T, Hofstra RM, de Bock GH, de Jong S, van der Zee AG, and de Vries EG

European journal of cancer (Oxford, England : 1990) 43(17):2495-505, 2007 Nov - Who cited this? | PubMed ID: 17949970 | Fulltext

P53-specific T cell responses in patients with malignant and benign ovarian tumors: implications for p53 based immunotherapy.

+ cite this

+ View Abstract

Lambeck A, Leffers N, Hoogeboom BN, Sluiter W, Hamming I, Klip H, ten Hoor K, Esajas M, van Oven M, Drijfhout JW, Platteel I, Offringa R, Hollema H, Melief K, van der Burg S, van der Zee A,

(show remaining authors)

International journal of cancer. Journal international du cancer 121(3):606, 2007 Aug 1 - Who cited this? | PubMed ID: 17415711 | Fulltext

In vivo VEGF imaging with radiolabeled bevacizumab in a human ovarian tumor xenograft.

+ cite this

+ View Abstract

Nagengast WB, de Vries EG, Hospers GA, Mulder NH, de Jong JR, Hollema H, Brouwers AH, van Dongen GA, Perk LR, and Lub-de Hooge MN

Journal of nuclear medicine : official publication, Society of Nuclear Medicine 48(8):1313-9, 2007 Aug - Who cited this? | PubMed ID: 17631557 | Fulltext

Loss of MSH2 protein expression is a risk factor in early stage cervical cancer.

+ cite this

+ View Abstract

Nijhuis ER, Nijman HW, Oien KA, Bell A, ten Hoor KA, Reesink-Peters N, Boezen HM, Hollema H, and van der Zee AG

Journal of clinical pathology 60(7):824-30, 2007 Jul - Who cited this? | PubMed ID: 17596548 | Fulltext

Sulindac treatment in hereditary non-polyposis colorectal cancer.

+ cite this

+ View Abstract

Rijcken FE, Hollema H, van der Zee AG, van der Sluis T, Boersma-van Ek W, and Kleibeuker JH

European journal of cancer (Oxford, England : 1990) 43(8):1251-6, 2007 May - Who cited this? | PubMed ID: 17434727 | Fulltext

Ras/ERK1/2-mediated STAT3 Ser727 phosphorylation by familial medullary thyroid carcinoma-associated RET mutants induces full activation of STAT3 and is required for c-fos promoter activation, cell mitogenicity, and transformation.

+ cite this

+ View Abstract

Plaza-Menacho I, van der Sluis T, Hollema H, Gimm O, Buys CH, Magee AI, Isacke CM, Hofstra RM, and Eggen BJ

The Journal of biological chemistry 282(9):6415-24, 2007 Mar 2 - Who cited this? | PubMed ID: 17209045 | Fulltext

EGFR expression is associated with groin node metastases in vulvar cancer, but does not improve their prediction.

+ cite this

+ View Abstract

Oonk MH, de Bock GH, van der Veen DJ, Ten Hoor KA, de Hullu JA, Hollema H, and van der Zee AG

Gynecologic oncology 104(1):109-13, 2007 Jan - Who cited this? | PubMed ID: 16963112 | Fulltext

Value of RT-PCR analysis of sentinel nodes in determining the pathological nodal status in colon cancer.

+ cite this

+ View Abstract

Kelder W, Braat A, van den Berg A, Platteel I, Hollema H, Groen H, and Plukker J

Anticancer research 27(4C):2855-9, 2007 - Who cited this? | PubMed ID: 17695460 | Fulltext

Identification of mismatch repair gene mutations in young patients with colorectal cancer and in patients with multiple tumours associated with hereditary non-polyposis colorectal cancer.

+ cite this

+ View Abstract

Niessen RC, Berends MJ, Wu Y, Sijmons RH, Hollema H, Ligtenberg MJ, de Walle HE, de Vries EG, Karrenbeld A, Buys CH, van der Zee AG, Hofstra RM, and Kleibeuker JH

Gut 55(12):1781-8, 2006 Dec - Who cited this? | PubMed ID: 16636019 | Fulltext

Prognostic significance of tumor necrosis factor-related apoptosis-inducing ligand and its receptors in adjuvantly treated stage III colon cancer patients.

+ cite this

+ View Abstract

van Geelen CM, Westra JL, de Vries EG, Boersma-van Ek W, Zwart N, Hollema H, Boezen HM, Mulder NH, Plukker JT, De Jong S, Kleibeuker JH, and Koornstra JJ

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 24(31):4998, 2006 Nov 1 - Who cited this? | PubMed ID: 17075118 | Fulltext

Gynecologic examination and cervical biopsies after (chemo) radiation for cervical cancer to identify patients eligible for salvage surgery.

+ cite this

+ View Abstract

Nijhuis ER, van der Zee AG, in 't Hout BA, Boomgaard JJ, de Hullu JA, Pras E, Hollema H, Aalders JG, Nijman HW, Willemse PH, and Mourits MJ

International journal of radiation oncology, biology, physics 66(3):699-705, 2006 Nov 1 - Who cited this? | PubMed ID: 16904839 | Fulltext

Assessment of gene promoter hypermethylation for detection of cervical neoplasia.

+ cite this

+ View Abstract

Wisman GB, Nijhuis ER, Hoque MO, Reesink-Peters N, Koning AJ, Volders HH, Buikema HJ, Boezen HM, Hollema H, Schuuring E, Sidransky D, and van der Zee AG

International journal of cancer. Journal international du cancer 119(8):1908-14, 2006 Oct 15 - Who cited this? | PubMed ID: 16736496 | Fulltext

Factors influencing p53 expression in ovarian cancer as a biomarker of clinical outcome in multicentre studies.

+ cite this

+ View Abstract

de Graeff P, Hall J, Crijns AP, de Bock GH, Paul J, Oien KA, ten Hoor KA, De Jong S, Hollema H, Bartlett JM, Brown R, and van der Zee AG

British journal of cancer 95(5):627, 2006 Sep 4 - Who cited this? | PubMed ID: 16880779 | Fulltext

TRAIL-receptor expression is an independent prognostic factor for survival in patients with a primary glioblastoma multiforme.

+ cite this

+ View Abstract

Kuijlen JM, Mooij JJ, Platteel I, Hoving EW, van der Graaf WT, Span MM, Hollema H, and den Dunnen WF

Journal of neuro-oncology 78(2):161-71, 2006 Jun - Who cited this? | PubMed ID: 16544055 | Fulltext

Aromatase in the context of breast and endometrial cancer. A review.

+ cite this

+ View Abstract

Jongen VH, Hollema H, Van Der Zee AG, and Heineman MJ

Minerva endocrinologica 31(1):47-60, 2006 Mar - Who cited this? | PubMed ID: 16498363 | Fulltext

Cell cycle regulators and apoptosis-associated proteins in relation to proliferative activity and degree of apoptosis in HNPCC versus sporadic endometrial carcinoma.

+ cite this

+ View Abstract

Rijcken F, van der Zee A, van der Sluis T, Boersma-van Ek W, Kleibeuker J, and Hollema H

Histopathology 48(3):275-85, 2006 Feb - Who cited this? | PubMed ID: 16430474 | Fulltext

Prediction of lymph node metastases in vulvar cancer: a review.

+ cite this

+ View Abstract

Oonk MH, Hollema H, de Hullu JA, and van der Zee AG

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 16(3):963-71, 2006 - Who cited this? | PubMed ID: 16803470 | Fulltext

An overview of innovative techniques to improve cervical cancer screening.

+ cite this

+ View Abstract

Nijhuis ER, Reesink-Peters N, Wisman GB, Nijman HW, van Zanden J, Volders H, Hollema H, Suurmeijer AJ, Schuuring E, and van der Zee AG

Cellular oncology : the official journal of the International Society for Cellular Oncology 28(5-6):233-46, 2006 - Who cited this? | PubMed ID: 17167177 | Fulltext

Predictive value of thymidylate synthase and dihydropyrimidine dehydrogenase protein expression on survival in adjuvantly treated stage III colon cancer patients.

+ cite this

+ View Abstract

Westra JL, Hollema H, Schaapveld M, Platteel I, Oien KA, Keith WN, Mauritz R, Peters GJ, Buys CH, Hofstra RM, and Plukker JT

Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 16(10):1646-53, 2005 Oct - Who cited this? | PubMed ID: 16012177 | Fulltext

Determination of TP53 mutation is more relevant than microsatellite instability status for the prediction of disease-free survival in adjuvant-treated stage III colon cancer patients.

+ cite this

+ View Abstract

Westra JL, Schaapveld M, Hollema H, de Boer JP, Kraak MM, de Jong D, ter Elst A, Mulder NH, Buys CH, Hofstra RM, and Plukker JT

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 23(24):5635-43, 2005 Aug 20 - Who cited this? | PubMed ID: 16110022 | Fulltext

Prognostic role of cyclooxygenase-2 expression in esophageal carcinoma.

+ cite this

+ View Abstract

Heeren P, Plukker J, van Dullemen H, Nap R, and Hollema H

Cancer letters 225(2):283-9, 2005 Jul 28 - Who cited this? | PubMed ID: 15978332 | Fulltext

Sulindac inhibits beta-catenin expression in normal-appearing colon of hereditary nonpolyposis colorectal cancer and familial adenomatous polyposis patients.

+ cite this

+ View Abstract

Koornstra JJ, Rijcken FE, Oldenhuis CN, Zwart N, van der Sluis T, Hollema H, deVries EG, Keller JJ, Offerhaus JA, Giardiello FM, and Kleibeuker JH

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 14(7):1608, 2005 Jul - Who cited this? | PubMed ID: 16030090 | Fulltext

Presentations of endometrial activity after curative radiotherapy for cervical cancer.

+ cite this

+ View Abstract

de Hullu JA, Pras E, Hollema H, van der Zee AG, Bogchelman DH, and Mourits MJ

Maturitas 51(2):172-6, 2005 Jun 16 - Who cited this? | PubMed ID: 15917158 | Fulltext

A substantial proportion of microsatellite-unstable colon tumors carry TP53 mutations while not showing chromosomal instability.

+ cite this

+ View Abstract

Westra JL, Boven LG, van der Vlies P, Faber H, Sikkema B, Schaapveld M, Dijkhuizen T, Hollema H, Buys CH, Plukker JT, Kok K, and Hofstra RM

Genes, chromosomes & cancer 43(2):194-201, 2005 Jun - Who cited this? | PubMed ID: 15729700 | Fulltext

Expression of tumour necrosis factor-related apoptosis-inducing ligand death receptors in sporadic and hereditary colorectal tumours: potential targets for apoptosis induction.

+ cite this

+ View Abstract

Koornstra JJ, Jalving M, Rijcken FE, Westra J, Zwart N, Hollema H, de Vries EG, Hofstra RW, Plukker JT, de Jong S, and Kleibeuker JH

European journal of cancer (Oxford, England : 1990) 41(8):1195-202, 2005 May - Who cited this? | PubMed ID: 15911244 | Fulltext

Search Google Scholar for Hollema H

Join Labmeeting

Organize and search your PDF collection
Collect papers
Search millions of papers
Keep up to date with paper alerts
Read your papers from anywhere
Recommend papers to colleagues
Manage your lab

Labmeeting is a web service for researchers. Sign up with your academic email address.

Individuals or corporations not affiliated with an academic institution can request a trial subscription.

Got a question?
The Labmeeting Network
has the answer.
Ask scientists at top universities like Harvard, Stanford, and MIT for their expert opinion!